These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17620837)

  • 1. Development of a new generation of propofol.
    Wang H; Cork R; Rao A
    Curr Opin Anaesthesiol; 2007 Aug; 20(4):311-5. PubMed ID: 17620837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propofol: the challenges of formulation.
    Baker MT; Naguib M
    Anesthesiology; 2005 Oct; 103(4):860-76. PubMed ID: 16192780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free radical and drug oxidation products in an intensive care unit sedative: propofol with sulfite.
    Baker MT; Gregerson MS; Martin SM; Buettner GR
    Crit Care Med; 2003 Mar; 31(3):787-92. PubMed ID: 12626985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New drug, fospropofol disodium: a propofol prodrug.
    Welliver M; Rugari SM
    AANA J; 2009 Aug; 77(4):301-8. PubMed ID: 19731849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative propofol emulsion stabilities.
    Baker MT
    AANA J; 2000 Aug; 68(4):287. PubMed ID: 11125598
    [No Abstract]   [Full Text] [Related]  

  • 6. Sulfite-induced propofol oxidation: a cause for radical concern.
    Zaloga GP; Marik P
    Crit Care Med; 2003 Mar; 31(3):981-3. PubMed ID: 12627021
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of nimodipine, fentanyl and remifentanil intravenous products on the stability of propofol emulsions.
    Nemec K; Germ E; Schulz-Siegmund M; Ortner A
    Pharmazie; 2009 Feb; 64(2):94-7. PubMed ID: 19320281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical and Chemical Compatibility of Etomidate and Propofol Injectable Emulsions.
    Wang C; Wang S; Wu C; Lei L; Wang DX; Zhang Q
    Pharmacology; 2021; 106(11-12):644-657. PubMed ID: 34644710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Preservatives" in propofol.
    Craig DB
    Can J Anaesth; 1998 Sep; 45(9):913. PubMed ID: 9818119
    [No Abstract]   [Full Text] [Related]  

  • 10. The universality of low-energy nano-emulsification.
    Anton N; Vandamme TF
    Int J Pharm; 2009 Jul; 377(1-2):142-7. PubMed ID: 19454306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and Evaluation of Multidose Propofol Nanoemulsion Using Statistically Designed Experiments.
    Hota SS; Pattnaik S; Mallick S
    Acta Chim Slov; 2020 Mar; 67(1):179-188. PubMed ID: 33558914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclodextrins as new formulation entities and therapeutic agents.
    Sikharam S; Egan TD; Kern SE
    Curr Opin Anaesthesiol; 2005 Aug; 18(4):392-5. PubMed ID: 16534264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chemical and physical stability of a 1:1 mixture of propofol and methohexital.
    Bennett J; Gross J; Nichols F; Chidambaram N; Burgess D
    Anesth Prog; 2001; 48(2):61-5. PubMed ID: 11515949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid dissolution of propofol emulsions under sink conditions.
    Damitz R; Chauhan A
    Int J Pharm; 2015 Mar; 481(1-2):47-55. PubMed ID: 25636303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pickering w/o emulsions: drug release and topical delivery.
    Frelichowska J; Bolzinger MA; Valour JP; Mouaziz H; Pelletier J; Chevalier Y
    Int J Pharm; 2009 Feb; 368(1-2):7-15. PubMed ID: 18992799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fat-globule size in a propofol emulsion containing sodium metabisulfite.
    Driscoll DF; Dunbar JG; Marmarou A
    Am J Health Syst Pharm; 2004 Jun; 61(12):1276-80. PubMed ID: 15259759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in lipid nanodispersions for parenteral drug delivery and targeting.
    Constantinides PP; Chaubal MV; Shorr R
    Adv Drug Deliv Rev; 2008 Mar; 60(6):757-67. PubMed ID: 18096269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel lipid and preservative-free propofol formulation: properties and pharmacodynamics.
    Ravenelle F; Gori S; Le Garrec D; Lessard D; Luo L; Palusova D; Sneyd JR; Smith D
    Pharm Res; 2008 Feb; 25(2):313-9. PubMed ID: 18030606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sevoflurane and propofol: original and generic].
    Al-Nasser B
    Ann Fr Anesth Reanim; 2008 Jan; 27(1):120-2. PubMed ID: 18191934
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of electrokinetic stabilizers on the physicochemical properties of propofol emulsions.
    Rhee YS; Park CW; Oh TO; Kim JY; Ha JM; Lee BJ; Lee KH; Chi SC; Park ES
    Int J Pharm; 2010 Oct; 398(1-2):21-7. PubMed ID: 20637850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.